APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostate Specific Antigen

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prostate Specific Antigen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025186 pages

Choose your research edition.

Industry ResearchProstate Specific Antigen Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Specific Antigen Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Prostate Specific Antigen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Specific Antigen Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Specific Antigen Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Prostate Specific Antigen market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prostate Specific Antigen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostate Specific Antigen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostate Specific Antigen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prostate Specific Antigen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostate Specific Antigen include OncBioMune Pharmaceuticals Inc., Inovio Pharmaceuticals, Inc., GenSpera, Inc., Curevac AG, Bavarian Nordic A/S, Aeterna Zentaris Inc. and Advaxis, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostate Specific Antigen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostate Specific Antigen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostate Specific Antigen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostate Specific Antigen market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostate Specific Antigen Segment by Company

OncBioMune Pharmaceuticals Inc.

Inovio Pharmaceuticals, Inc.

GenSpera, Inc.

Curevac AG

Bavarian Nordic A/S

Aeterna Zentaris Inc.

Advaxis, Inc.

Prostate Specific Antigen Segment by Type

INO-5150

G-115

AEZS-120

ADXS-PSA

Others

Prostate Specific Antigen Segment by Application

Prostate Cancer

Metastatic Hormone Refractory Prostate Cancer

Others

Prostate Specific Antigen Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Specific Antigen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Specific Antigen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Specific Antigen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostate Specific Antigen market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostate Specific Antigen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prostate Specific Antigen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prostate Specific Antigen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prostate Specific Antigen Industry Trends Table 2. Prostate Specific Antigen Industry Drivers Table 3. Prostate Specific Antigen Industry Opportunities and Challenges Table 4. Prostate Specific Antigen Industry Restraints Table 5. Global Prostate Specific Antigen Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prostate Specific Antigen Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prostate Specific Antigen Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Prostate Specific Antigen Sales Market Share by Manufacturers Table 9. Global Prostate Specific Antigen Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Prostate Specific Antigen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prostate Specific Antigen Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prostate Specific Antigen Manufacturers, Product Type & Application Table 13. Global Prostate Specific Antigen Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostate Specific Antigen by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of INO-5150 Table 17. Major Manufacturers of G-115 Table 18. Major Manufacturers of AEZS-120 Table 19. Major Manufacturers of ADXS-PSA Table 20. Major Manufacturers of Others Table 21. Global Prostate Specific Antigen Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Prostate Specific Antigen Sales by Type (2021-2026) & (W Units) Table 23. Global Prostate Specific Antigen Sales by Type (2027-2032) & (W Units) Table 24. Global Prostate Specific Antigen Sales Market Share by Type (2021-2026) Table 25. Global Prostate Specific Antigen Sales Market Share by Type (2027-2032) Table 26. Global Prostate Specific Antigen Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Prostate Specific Antigen Revenue by Type (2021-2026) & (W Units) Table 28. Global Prostate Specific Antigen Revenue by Type (2027-2032) & (W Units) Table 29. Global Prostate Specific Antigen Revenue Market Share by Type (2021-2026) Table 30. Global Prostate Specific Antigen Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Prostate Cancer Table 32. Major Manufacturers of Metastatic Hormone Refractory Prostate Cancer Table 33. Major Manufacturers of Others Table 34. Global Prostate Specific Antigen Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Prostate Specific Antigen Sales by Application (2021-2026) & (W Units) Table 36. Global Prostate Specific Antigen Sales by Application (2027-2032) & (W Units) Table 37. Global Prostate Specific Antigen Sales Market Share by Application (2021-2026) Table 38. Global Prostate Specific Antigen Sales Market Share by Application (2027-2032) Table 39. Global Prostate Specific Antigen Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 40. Global Prostate Specific Antigen Revenue by Application (2021-2026) & (W Units) Table 41. Global Prostate Specific Antigen Revenue by Application (2027-2032) & (W Units) Table 42. Global Prostate Specific Antigen Revenue Market Share by Application (2021-2026) Table 43. Global Prostate Specific Antigen Revenue Market Share by Application (2027-2032) Table 44. Global Prostate Specific Antigen Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Prostate Specific Antigen Sales by Region (2021-2026) & (W Units) Table 46. Global Prostate Specific Antigen Sales Market Share by Region (2021-2026) Table 47. Global Prostate Specific Antigen Sales Forecasted by Region (2027-2032) & (W Units) Table 48. Global Prostate Specific Antigen Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. North America Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 51. North America Prostate Specific Antigen Sales by Country (2027-2032) & (W Units) Table 52. Europe Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Europe Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 54. Europe Prostate Specific Antigen Sales by Country (2027-2032) & (W Units) Table 55. Asia Pacific Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Asia Pacific Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 57. Asia Pacific Prostate Specific Antigen Sales by Country (2027-2032) & (W Units) Table 58. South America, Middle East and Africa Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. South America, Middle East and Africa Prostate Specific Antigen Sales by Country (2021-2026) & (W Units) Table 60. South America, Middle East and Africa Prostate Specific Antigen Sales by Country (2027-2032) & (W Units) Table 61. Global Prostate Specific Antigen Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Prostate Specific Antigen Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Prostate Specific Antigen Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Prostate Specific Antigen Revenue Market Share by Region (2021-2026) Table 65. Global Prostate Specific Antigen Revenue Market Share by Region (2027-2032) Table 66. OncBioMune Pharmaceuticals Inc. Company Information Table 67. OncBioMune Pharmaceuticals Inc. Business Overview Table 68. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolio Table 70. OncBioMune Pharmaceuticals Inc. Recent Development Table 71. Inovio Pharmaceuticals, Inc. Company Information Table 72. Inovio Pharmaceuticals, Inc. Business Overview Table 73. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolio Table 75. Inovio Pharmaceuticals, Inc. Recent Development Table 76. GenSpera, Inc. Company Information Table 77. GenSpera, Inc. Business Overview Table 78. GenSpera, Inc. Prostate Specific Antigen Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GenSpera, Inc. Prostate Specific Antigen Product Portfolio Table 80. GenSpera, Inc. Recent Development Table 81. Curevac AG Company Information Table 82. Curevac AG Business Overview Table 83. Curevac AG Prostate Specific Antigen Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Curevac AG Prostate Specific Antigen Product Portfolio Table 85. Curevac AG Recent Development Table 86. Bavarian Nordic A/S Company Information Table 87. Bavarian Nordic A/S Business Overview Table 88. Bavarian Nordic A/S Prostate Specific Antigen Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Bavarian Nordic A/S Prostate Specific Antigen Product Portfolio Table 90. Bavarian Nordic A/S Recent Development Table 91. Aeterna Zentaris Inc. Company Information Table 92. Aeterna Zentaris Inc. Business Overview Table 93. Aeterna Zentaris Inc. Prostate Specific Antigen Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolio Table 95. Aeterna Zentaris Inc. Recent Development Table 96. Advaxis, Inc. Company Information Table 97. Advaxis, Inc. Business Overview Table 98. Advaxis, Inc. Prostate Specific Antigen Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Advaxis, Inc. Prostate Specific Antigen Product Portfolio Table 100. Advaxis, Inc. Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Prostate Specific Antigen Distributors List Table 104. Prostate Specific Antigen Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Prostate Specific Antigen Product Image Figure 2. Global Prostate Specific Antigen Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostate Specific Antigen Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostate Specific Antigen Sales (2021-2032) & (W Units) Figure 5. Global Prostate Specific Antigen Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prostate Specific Antigen Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. INO-5150 Image Figure 9. G-115 Image Figure 10. AEZS-120 Image Figure 11. ADXS-PSA Image Figure 12. Others Image Figure 13. Global Prostate Specific Antigen Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Prostate Specific Antigen Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Prostate Specific Antigen Sales Market Share by Type (2021-2032) Figure 16. Global Prostate Specific Antigen Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Prostate Specific Antigen Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Prostate Specific Antigen Revenue Market Share by Type (2021-2032) Figure 19. Prostate Cancer Image Figure 20. Metastatic Hormone Refractory Prostate Cancer Image Figure 21. Others Image Figure 22. Global Prostate Specific Antigen Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Prostate Specific Antigen Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Prostate Specific Antigen Sales Market Share by Application (2021-2032) Figure 25. Global Prostate Specific Antigen Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Prostate Specific Antigen Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Prostate Specific Antigen Revenue Market Share by Application (2021-2032) Figure 28. North America Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 29. North America Prostate Specific Antigen Sales Market Share by Country (2021-2032) Figure 30. U.S. Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Canada Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Mexico Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Prostate Specific Antigen Sales Market Share by Country (2021-2032) Figure 35. Germany Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 36. France Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 37. U.K. Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Italy Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Netherlands Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Prostate Specific Antigen Sales Market Share by Country (2021-2032) Figure 42. China Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Japan Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 44. South Korea Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Southeast Asia Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 46. India Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Australia Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Prostate Specific Antigen Sales Market Share by Country (2021-2032) Figure 50. Brazil Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South Africa Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Saudi Arabia Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Turkey Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Argentina Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 55. UAE Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Egypt Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Chile Prostate Specific Antigen Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Global Prostate Specific Antigen Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Prostate Specific Antigen Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Prostate Specific Antigen Revenue (2021-2032) & (US$ Million) Figure 61. North America Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Prostate Specific Antigen Revenue (2021-2032) & (US$ Million) Figure 63. Europe Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Prostate Specific Antigen Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Prostate Specific Antigen Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Prostate Specific Antigen Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Prostate Specific Antigen Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • INO-5150
  • G-115
  • AEZS-120
  • ADXS-PSA
  • Others
Applications
  • Prostate Cancer
  • Metastatic Hormone Refractory Prostate Cancer
  • Others
Companies covered
  • OncBioMune Pharmaceuticals Inc.
  • Inovio Pharmaceuticals, Inc.
  • GenSpera, Inc.
  • Curevac AG
  • Bavarian Nordic A/S
  • Aeterna Zentaris Inc.
  • Advaxis, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostate Specific Antigen Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostate Specific Antigen Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prostate Specific Antigen Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prostate Specific Antigen Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prostate Specific Antigen Market Dynamics
  1. 2.1 Prostate Specific Antigen Industry Trends
  2. 2.2 Prostate Specific Antigen Industry Drivers
  3. 2.3 Prostate Specific Antigen Industry Opportunities and Challenges
  4. 2.4 Prostate Specific Antigen Industry Restraints
3 Prostate Specific Antigen Market by Manufacturers
  1. 3.1 Global Prostate Specific Antigen Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prostate Specific Antigen Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prostate Specific Antigen Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prostate Specific Antigen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostate Specific Antigen Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prostate Specific Antigen Manufacturers, Product Type & Application
  7. 3.7 Global Prostate Specific Antigen Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostate Specific Antigen Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostate Specific Antigen Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostate Specific Antigen Tier 1, Tier 2, and Tier 3
4 Prostate Specific Antigen Market by Type
  1. 4.1 Prostate Specific Antigen Type Introduction
  2. 4.1.1 INO-5150
  3. 4.1.2 G-115
  4. 4.1.3 AEZS-120
  5. 4.1.4 ADXS-PSA
  6. 4.1.5 Others
  7. 4.2 Global Prostate Specific Antigen Sales by Type
  8. 4.2.1 Global Prostate Specific Antigen Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prostate Specific Antigen Sales by Type (2021-2032)
  10. 4.2.3 Global Prostate Specific Antigen Sales Market Share by Type (2021-2032)
  11. 4.3 Global Prostate Specific Antigen Revenue by Type
  12. 4.3.1 Global Prostate Specific Antigen Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Prostate Specific Antigen Revenue by Type (2021-2032)
  14. 4.3.3 Global Prostate Specific Antigen Revenue Market Share by Type (2021-2032)
5 Prostate Specific Antigen Market by Application
  1. 5.1 Prostate Specific Antigen Application Introduction
  2. 5.1.1 Prostate Cancer
  3. 5.1.2 Metastatic Hormone Refractory Prostate Cancer
  4. 5.1.3 Others
  5. 5.2 Global Prostate Specific Antigen Sales by Application
  6. 5.2.1 Global Prostate Specific Antigen Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostate Specific Antigen Sales by Application (2021-2032)
  8. 5.2.3 Global Prostate Specific Antigen Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prostate Specific Antigen Revenue by Application
  10. 5.3.1 Global Prostate Specific Antigen Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prostate Specific Antigen Revenue by Application (2021-2032)
  12. 5.3.3 Global Prostate Specific Antigen Revenue Market Share by Application (2021-2032)
6 Global Prostate Specific Antigen Sales by Region
  1. 6.1 Global Prostate Specific Antigen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostate Specific Antigen Sales by Region (2021-2032)
  3. 6.2.1 Global Prostate Specific Antigen Sales by Region (2021-2026)
  4. 6.2.2 Global Prostate Specific Antigen Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prostate Specific Antigen Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prostate Specific Antigen Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prostate Specific Antigen Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prostate Specific Antigen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prostate Specific Antigen Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prostate Specific Antigen Revenue by Region
  1. 7.1 Global Prostate Specific Antigen Revenue by Region
  2. 7.1.1 Global Prostate Specific Antigen Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prostate Specific Antigen Revenue by Region (2021-2026)
  4. 7.1.3 Global Prostate Specific Antigen Revenue by Region (2027-2032)
  5. 7.1.4 Global Prostate Specific Antigen Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prostate Specific Antigen Revenue (2021-2032)
  8. 7.2.2 North America Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prostate Specific Antigen Revenue (2021-2032)
  11. 7.3.2 Europe Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prostate Specific Antigen Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prostate Specific Antigen Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prostate Specific Antigen Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 OncBioMune Pharmaceuticals Inc.
  2. 8.1.1 OncBioMune Pharmaceuticals Inc. Company Information
  3. 8.1.2 OncBioMune Pharmaceuticals Inc. Business Overview
  4. 8.1.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolio
  6. 8.1.5 OncBioMune Pharmaceuticals Inc. Recent Developments
  7. 8.2 Inovio Pharmaceuticals, Inc.
  8. 8.2.1 Inovio Pharmaceuticals, Inc. Company Information
  9. 8.2.2 Inovio Pharmaceuticals, Inc. Business Overview
  10. 8.2.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolio
  12. 8.2.5 Inovio Pharmaceuticals, Inc. Recent Developments
  13. 8.3 GenSpera, Inc.
  14. 8.3.1 GenSpera, Inc. Company Information
  15. 8.3.2 GenSpera, Inc. Business Overview
  16. 8.3.3 GenSpera, Inc. Prostate Specific Antigen Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GenSpera, Inc. Prostate Specific Antigen Product Portfolio
  18. 8.3.5 GenSpera, Inc. Recent Developments
  19. 8.4 Curevac AG
  20. 8.4.1 Curevac AG Company Information
  21. 8.4.2 Curevac AG Business Overview
  22. 8.4.3 Curevac AG Prostate Specific Antigen Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Curevac AG Prostate Specific Antigen Product Portfolio
  24. 8.4.5 Curevac AG Recent Developments
  25. 8.5 Bavarian Nordic A/S
  26. 8.5.1 Bavarian Nordic A/S Company Information
  27. 8.5.2 Bavarian Nordic A/S Business Overview
  28. 8.5.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bavarian Nordic A/S Prostate Specific Antigen Product Portfolio
  30. 8.5.5 Bavarian Nordic A/S Recent Developments
  31. 8.6 Aeterna Zentaris Inc.
  32. 8.6.1 Aeterna Zentaris Inc. Company Information
  33. 8.6.2 Aeterna Zentaris Inc. Business Overview
  34. 8.6.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolio
  36. 8.6.5 Aeterna Zentaris Inc. Recent Developments
  37. 8.7 Advaxis, Inc.
  38. 8.7.1 Advaxis, Inc. Company Information
  39. 8.7.2 Advaxis, Inc. Business Overview
  40. 8.7.3 Advaxis, Inc. Prostate Specific Antigen Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Advaxis, Inc. Prostate Specific Antigen Product Portfolio
  42. 8.7.5 Advaxis, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostate Specific Antigen Value Chain Analysis
  2. 9.1.1 Prostate Specific Antigen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostate Specific Antigen Production Mode & Process
  6. 9.2 Prostate Specific Antigen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostate Specific Antigen Distributors
  9. 9.2.3 Prostate Specific Antigen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst